T2C2 Capital

T2C2 Capital

A venture capital and private equity firm investing in healthcare, information technology, business products, and services sectors.

T2C2 Capital (Technology, Transfer, Commercialisation, Capital) is a venture capital and private equity firm investing in healthcare, information technology, business products, and services sectors that is headquartered in Montreal, Quebec and was founded in 2003.

Investments

As of December 2019), T2C2 Capital has made 23 investments, has 1 company in its portfolio, and has made 12 exits. Notable investments made by T2C2 Capital include: Cytochroma, Aegera Therapeutics, Chronogen, LatroQuest, Cytheris, TransPharma Medical, BioAxone Therepautic, Enobia pharma, Topigen Pharmaceuticals, Quazal Technologies, and Interomex BioPharmaceuticals.

Timeline

Funded Companies

Company
Industry
Website
Location
Cytheris
2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.